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Abstract
Background: Human cytomegalovirus (HCMV) infection in the oral cavity plays an important role
in its horizontal transmission and in causing viral-associated oral diseases such as gingivitis.
However, little is currently known about HCMV pathogenesis in oral mucosa, partially because
HCMV infection is primarily limited to human cells and few cultured tissue or animal models are
available for studying HCMV infection.
Results: In this report, we studied the infection of HCMV in a cultured gingival tissue model
(EpiGingival, MatTek Co.) and investigated whether the cultured tissue can be used to study HCMV
infection in the oral mucosa. HCMV replicated in tissues that were infected through the apical
surface, achieving a titer of at least 300-fold at 10 days postinfection. Moreover, the virus spread
from the apical surface to the basal region and reduced the thickness of the stratum coreum at the
apical region. Viral proteins IE1, UL44, and UL99 were expressed in infected tissues, a characteristic
of HCMV lytic replication in vivo. Studies of a collection of eight viral mutants provide the first
direct evidence that a mutant with a deletion of open reading frame US18 is deficient in growth in
the tissues, suggesting that HCMV encodes specific determinants for its infection in oral mucosa.
Treatment by ganciclovir abolished viral growth in the infected tissues.
Conclusion: These results suggest that the cultured gingival mucosa can be used as a tissue model
for studying HCMV infection and for screening antivirals to block viral replication and transmission
in the oral cavity.
Background
Human cytomegalovirus (HCMV) is a ubiquitous herpes-
virus that causes mild or subclinical diseases in immuno-
competent adults but may lead to severe morbidity and
mortality in neonates and immunocompromised individ-
uals [1,2]. For example, disseminated HCMV infection,
common in AIDS patients and organ transplant recipi-
ents, is usually associated with gastroenteritis, pneumo-
nia, and retinitis [3,4]. Moreover, HCMV is one of the
leading causes of birth defects and mental retardation in
newborns [5,6]. Understanding the biology of CMV infec-
tion and developing novel anti-CMV approaches are cen-
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diseases.
HCMV infection in the oral cavity plays an important role
in its pathogenesis and transmission. HCMV is among the
most common causes of oral diseases associated with
AIDS patients [7,8]. Active viral replication in the oral tis-
sue induces CMV-associated oral manifestations such as
ulcerations, aphthous stomatitis, necrotizing gingivitis,
and acute periodontal infection [9-13]. Persistent and
latent infections have also been found in oral tissues. The
presence of infectious particles in the oral cavity including
saliva is believed to be a major source of HCMV horizon-
tal transmission [1,6]. Indeed, initial infection of the oral
mucosa by HCMV, primarily through casual contact, is
believed to be one of the major routes of horizontal trans-
mission among individuals, and the consequent viral rep-
lication and spread in oral tissues leads to the
establishment of lifelong latent infection. Elucidating the
mechanism of HCMV infection in the oral mucosa and
blocking viral replication in infected oral tissues are essen-
tial for the treatment and prevention of CMV transmission
and systemic infections.
HCMV belongs to the β family of herpesviruses and con-
tains a linear 230 kb double-stranded DNA genome that
is predicted to encode more than 200 proteins [14,15].
There are currently few animal models available to study
HCMV infection and pathogenesis and to determine effi-
cacy of various antiviral therapies. This is largely due to
the fact that HCMV infection and replication are limited
to human cells [1,2]. Consequently, little is known about
the mechanism of viral pathogenesis, such as how HCMV
infects the oral mucosa.
One of the most powerful approaches to study viral
pathogenesis is to develop a cultured tissue model that
can mimic natural infection in human tissues in vivo. The
SCID-hu mouse, in which different fetal human tissues
are implanted into the kidney capsule of a severe com-
bined immunodeficient (SCID) mouse, has been shown
to be a useful model to study HCMV replication and to
screen antiviral compounds in human tissues [16,17]. In
these animals, the implanted human fetal tissues con-
tinue to grow and differentiate. HCMV was directly inoc-
ulated into the implanted tissues and viral replication was
monitored. SCID-hu mice implanted with different
human tissues from the liver, thymus, bone, retina, and
skin have been shown to support HCMV replication and
can be used as models to study HCMV infection in these
human tissues in vivo [16,18]. However, the difficulty in
generating these animals limits the use of the models. Fur-
thermore, the use of fetal tissues in SCID mice presents a
challenge to study HCMV infection in adult tissues, such
as in the oral mucosa, because the implanted tissues need
to differentiate properly into adult tissues in the mouse
microenvironment. Currently, no SCID mice with human
oral mucosa implants have been reported.
Recently, three-dimensional models of the human oral
epithelia that exhibit a buccal or gingival phenotype, such
as EpiGingival from MatTek, Co., have been developed
[19-22]. In these models, normal human keratinocytes are
differentiated into tissues in serum free media. The gingi-
val model has 10–20 layers of viable, nucleated cells and
is partially cornified at the apical surface. These models
exhibit very similar histological characteristics to human
oral tissues in vivo. Thus, they can serve as a tissue model
for human oral epithelia, such as gingival mucosa, and
can potentially be used to study oral physiology and trans-
mission of infectious pathogens.
The development of reconstructed tissues of human oral
cavity provides an invaluable cultured tissue system for
studying the biology of CMV infection. To study the func-
tion of viral-encoded genes in supporting HCMV infec-
tion, we can generate a collection of viral mutants by
introducing mutations into the viral genome and screen-
ing viral mutants in both cultured cells and tissues for
potential growth defects [23]. The construction of HCMV
mutants has been reported using site-directed homolo-
gous recombination and cosmid libraries of overlapping
viral DNA fragments, and recently, using a bacterial artifi-
cial chromosome (BAC)-based approach [24-30]. Exam-
ining the growth of these mutants in the oral tissue model
should facilitate the identification of viral genes responsi-
ble for HCMV tropism in the oral mucosa and for trans-
mission. Furthermore, the tissue model can be used for
screening antiviral compounds and for developing novel
strategies for preventing HCMV infection in oral cavity
and its transmission among human populations.
In this study, we examined the infection of HCMV in a
cultured gingival mucosa model (EpiGingival, MatTek
Co.) and determined whether the cultured tissue is suita-
ble to study HCMV infection in vivo. Both laboratory-
adapted viral strain and low-passaged clinical isolate were
shown to infect the human tissue via the apical surface.
Investigation of the growth of these viruses indicates that
the viral strains replicate at a similar level, reaching a 300-
fold higher titer after 10 days post infection. Histological
examination of tissues infected via the apical surface indi-
cated that these viruses spread from the apical surface to
the suprabasal region. Moreover, Western analyses dem-
onstrated the expression of viral proteins IE1, UL44, and
UL99 in the infected tissues, suggesting that the infection
process represents a classic lytic replication that is associ-
ated with primary HCMV infection in vivo. Growth stud-
ies of a collection of eight viral mutants indicated that a
mutant with deletion at open reading frame US18 is defi-Page 2 of 13
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infected tissues with ganciclovir, which is effective for
anti-HCMV therapy in vivo [31,32], abolished viral
growth in the cultured tissues. These results provide the
first direct evidence that the cultured gingival mucosa is an
excellent tissue model for studying HCMV infection in
vivo and for screening antiviral compounds to block
HCMV infection and transmission in the oral cavity.
Results
Growth of different HCMV strains in cultured human oral 
tissue
The MatTek gingival tissue model (EpiGingival) contains
normal human oral keratinocytes cultured in serum-free
medium to form three-dimensional differentiated tissues.
Hematoxylin and eosin staining of tissue cross-sections
indicates that the cultured tissue shows an architecture
very similar to human gingival mucosa in vivo (Figure 1,
see Figure 4A) [22]. The cultured tissue is 10–20 cell layers
thick and consists of a cornified apical surface and a non-
cornified basal region (Figure 1). The thickness and mor-
phology of the apical stratum corneum and the basal cell
layers are similar to those in the gingival tissues in vivo. As
observed in vivo, cells at the basal region of the cultured
tissue continue to divide and differentiate, and apical sur-
face cells continue to cornify to form the stratum cor-
neum. Furthermore, immunohistochemical staining
indicates that distributions of different cytokeratins (e.g.
K13 and K14) in cultured tissues are like those found in
vivo [22,33] (data not shown). Thus, the cultured tissue
exhibits characteristics in structure (thickness, morphol-
ogy, and organization), cell type and differentiation, and
protein expression and composition as observed in vivo,
and can be a model representing the oral tissue [22].
To determine whether the cultured tissues are permissive
to HCMV infection and replication, two different HCMV
Growth of different HCMV strains (Toledo, Towne, and TowneBAC) in cultured cells (A) and cultured gingival tissues (B)Figure 2
Growth of different HCMV strains (Toledo, Towne, and TowneBAC) in cultured cells (A) and cultured gingival tissues (B). In 
(A), human foreskin fibroblasts (HFFs) (1 × 106 cells) were infected with each virus at a MOI of 0.05. At 0, 2, 4, 7, 10, and 14 
days post infection, cells and culture media were harvested and sonicated. In (B), the tissues were infected with 2 × 104 PFU of 
each virus at the apical surface of the tissue. At 0, 3, 6, and 10 days post infection, the tissues were harvested, suspended in a 
small volume of 10% milk, and sonicated. The viral titers were determined by plaque assays on HFFs. The limit of detection was 
10 PFU/ml of the tissue homogenate. The values of the viral titer represent the average obtained from triplicate experiments. 
The standard deviation is indicated by the error bars.
Hematoxylin and eosin staining of EpiGingival tissues (magni-fication, ×400)Figure 1
Hematoxylin and eosin staining of EpiGingival tissues (magni-
fication, ×400). Upon arrival, the tissues were cultured for 12 
hours prior to viral infection, fixed with Streck Tissue Fixa-
tive, frozen in 2-methylbutane submerged in liquid nitrogen, 
cross-sectioned at 9 µm using a LEICA cryostat LC1900 sec-
tioner, stained with hematoxylin and eosin, and visualized 
with a Nikon TE300 microscope.Page 3 of 13
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were used in our initial experiments. Towne is a labora-
tory-adopted strain that has been passaged many times in
vitro in human fibroblasts; whereas Toledo is an HCMV
clinical isolate passaged in limited numbers in vitro
[34,35]. TowneBAC was derived from Towne by inserting a
bacterial artificial chromosome (BAC) sequence into the
viral genome and replacing the dispensable, 10 kb US1-
US12 region [36]. The TowneBAC DNA, while maintained
as a BAC-based plasmid in E. coli, produces infectious
progeny in human fibroblasts and retains a wild type-like
growth characteristic in vitro (Figure 2A) [23,36]. Each of
these viruses was used to infect the tissues by inoculating
at the apical surface with 2 × 104 PFU. The infection
through the apical surface serves as a model for HCMV
infection via gingival mucosa surface. The infection was
carried out for 10 days. We observed that the structure of
the tissue remained intact up to 10 days in culture and
started to disintegrate after 12 days incubation (data not
shown). At different time points post infection, the tissues
were harvested and the titers of the viruses were deter-
mined. The viral strains were able to grow in the tissues
since viral titers increased by at least 300-fold during a 10
day infection period (Figure 2B). Thus, the gingival tissues
support active HCMV lytic replication. No differences in
growth among these viruses were found, suggesting that
the lab-adopted Towne strain and its derivative, Towne-
BAC, grow as well as the clinical low-passaged Toledo
strain. In subsequent experiments, TowneBAC was used as
an HCMV representative to study viral infection in the gin-
gival tissues. This mutant contains the gene coding for
green fluorescence protein (GFP) and therefore, infection
can be easily monitored in the tissues by detecting GFP
expression [23,36].
Viral protein expression and histological changes in 
cultured human oral tissue upon HCMV infection
HCMV oral transmission begins when the virus enters the
mucosal (apical) surface of oral tissues (e.g. gingival tis-
sues), replicates in the surface cell layers, and spreads to
neighboring cells and tissues in the basal regions [1,7]. To
determine whether HCMV infection of the MatTek gingi-
val tissues can be a model for viral infection in vivo, two
sets of experiments were carried out. First, Western analy-
sis was used to determine whether viral lytic proteins were
expressed, as observed in productive HCMV infection in
vivo. Tissues were infected with 2 × 104 PFU of either
HCMV Toledo, Towne, or TowneBAC strains. Protein
extracts were isolated from tissues that were either mock-
infected or infected with HCMV at 6 days post infection.
Viral proteins were separated electrophoretically in SDS-
polyacrylamide gels and electrically transferred to identi-
cal membranes. One of the membranes was stained with
monoclonal antibody against human actin (anti-actin)
(Figure 3D) and the other membranes were stained with
Expression of HCMV lytic proteins as determined by West-ern blot a alysisFigure 3
Expression of HCMV lytic proteins as determined by West-
ern blot analysis. Protein samples were isolated from the cul-
tured EpiGingival tissues that were either mock-infected 
(lanes 1, 5, 9, and 13) or infected with HCMV (2 × 104 PFU) 
(lanes 2–4, 6–8, 10–12, and 14–16) for 6 days, separated in 
SDS-polyacrylamide gels, and then transferred to mem-
branes. One membrane was allowed to react with a mono-
clonal antibody (Anti-actin) against human actin (D) while the 
others were stained with the antibodies (Anti-IE1, Anti-
UL44, and Anti-UL99) against HCMV IE1, UL44, or UL99, 
respectively (A-C). The expression of human actin was used 
as the internal control for the quantitation of the expression 
of HCMV proteins.Page 4 of 13
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proteins (Figure 3A–C). The expression of actin serves as
an internal control for the quantitation of HCMV protein
expression in the tissues. IE1 is a viral immediate-early (α)
protein, while UL44 and UL99 encode viral early (β) and
late (γ) proteins, respectively [2]. These proteins serve as
the representatives for the expression of viral α, β, and γ
genes. As shown in Figure 3, IE1, UL44 and UL99 were
expressed in infected tissues. Combined with the growth
analysis (Figure 2), these results indicate that the cultured
tissues are permissive to HCMV infection and can support
viral lytic gene expression and replication.
In the second set of experiments, infection of these tissues
was studied using both conventional histological and flu-
orescent microscopy. Two different staining methods
were employed. First, tissues were stained with hematoxy-
lin and eosin in order to examine their structures. Second,
since TowneBAC contains a GFP expression cassette [36],
fluorescent microscopy was used to detect GFP expression
and to visualize infected cells.
As shown in Figure 4, mock-infected tissues maintained
the characteristic gingival mucosal structure during the
infection period. In these tissues, the cells at the basal sur-
face continue to divide while those at the apical surface
differentiate and cornify, forming a characteristic stratum
corneum (Figure 4A). In the tissues that were infected
through the apical surface, GFP staining was found in the
cells near the apical surface, suggesting that the apical cells
were infected with HCMV (Figure 4C–F). Compared to
mock-infected tissues, the thickness of the stratum cor-
neum in the infected tissues was significantly reduced
(Figure 4B), possibly because the active replication of
HCMV in apical cells induces cellular lysis and disrupts
cellular differentiation and generation of the stratum cor-
neum. Active HCMV replication in the apical surface has
been observed in vivo and is associated with reduced
thickness and destruction of the oral epithelial surface
[1,9,11]. Thus, our results suggest that HCMV infection of
cultured gingival tissues via the apical surface corresponds
to its pathogenesis in vivo.
Deficient growth of HCMV mutants in infected human oral 
tissues
The ability of HCMV to infect and replicate in cells of the
oral cavity is responsible for its pathogenesis in the oral
mucosa, including viral-associated gingivitis and oral
lesions. However, little is currently known about the
mechanism of how HCMV is able to infect and replicate
in oral tissues. Equally elusive is the identity of viral deter-
minants responsible for oral infection. Specifically, it is
unknown whether HCMV encodes specific genes respon-
sible for its infection in the gingival mucosa. Through the
use of a BAC-based mutagenesis approach, we have
recently generated a library of HCMV mutants containing
deletions in each open reading frame (ORF) [23]. If a viral
ORF is essential for viral infection in the oral tissue, the
corresponding mutant with the deletion of the ORF is
expected to be deficient in infecting and replicating in the
tissue. Using the gingival tissue as the model, several
experiments were performed to determine whether viral
mutants that are attenuated in growth in the oral mucosa
can be identified.
A collection of eight different mutants was used in our ini-
tial screen (Table 1). Each mutant was derived from
TowneBAC and contains a deletion in ORF UL13, UL24,
UL25, UL108, US18, US20, US29, or RL9, respectively
[23]. In these mutants, the deleted ORF sequence was
replaced with a kanamycin-resistance gene (KAN) expres-
sion cassette, which provides antibiotic resistance for
rapid selection and isolation of the bacteria carrying the
mutated TowneBAC sequence. All mutants grew as well as
the parental TowneBAC in primary human foreskin fibrob-
lasts (HFFs), suggesting that these ORFs are not essential
for viral replication in vitro in cultured fibroblasts (Table
I and Figure 5A). The functions of many of these deleted
ORFs are currently unknown. However, they are present
in all HCMV strains whose sequences have been deter-
mined [14,15,23,37,38]. Hence, these genes may play an
important role in HCMV infection in vivo, such as in viral
transmission and infection in the oral cavity.
To determine whether any of these HCMV mutants are
deficient in growth and infection in cultured gingival tis-
sues, the tissues were infected via the apical mucosal sur-
face with each viral mutant at an inoculum of 2 × 104
PFU. Infected tissues were harvested at 10 days post infec-
tion and viral titers in the tissues were determined. The tit-
Table 1: Comparison of the growth properties of eight different 
mutants in primary human foreskin fibroblasts (HFFs) and 
cultured human gingival tissues (Gingival tissues) with those of 
the parental TowneBAC.
Mutants HFFs Gingival Tissue
TowneBAC +++ +++∆UL13 +++ ++
∆UL24 +++ +++
∆UL25 +++ +++
∆UL108 +++ +++
∆US18 +++ +
∆US20 +++ +++
∆US29 +++ +++
∆RL9 +++ +++
Cells (1 × 106 HFFs) or tissues were infected with each virus at 2 × 
104 PFU and at 10 days post-infection, cells and tissues were 
harvested and sonicated. The viral titers were determined by plaque 
assays on HFFs in triplicate experiments [46]. +++, titer similar to 
that of TowneBAC; ++, titer about 10 times lower than that of 
TowneBAC; +, titer at least 100 times lower than that of TowneBAC.Page 5 of 13
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were approximately 100- and 10- folds lower than those
of the parental TowneBAC, respectively, while other
mutants, such as ∆UL24 and ∆RL9, replicated as well as
the parental virus (Table I and Figure 5B). Thus, mutants
∆UL13 and ∆US18 appeared to be deficient in infecting
the tissues via the apical surface. Both ∆UL13 and ∆US18
were derived from the parental TowneBAC by replacing
the UL13 and US18 ORFs, respectively, with a DNA
sequence (KAN) that confers antibiotic resistance to kan-
amycin in E. coli [23]. Because ∆RL9 replicates as well as
the parental TowneBAC (Figure 5), the presence of the
KAN cassette in the viral genome per se does not signifi-
cantly affect the ability of the virus to grow in the tissues.
Thus, these results suggest that the growth defect of
∆US18 may be due to the deletion of the US18 ORF.
Two series of experiments were further carried out to study
how ∆US18 is defective in growth in the cultured tissues.
First, viral infection in the tissues was studied by examin-
ing hematoxylin and eosin-stained tissues and visualizing
GFP expression in infected cells. At 7 days post infection,
the structure of the apical region in the ∆US18-infected
tissues was similar to that of uninfected tissues, and the
thickness of the stratum corneum was not reduced as
observed in the TowneBAC-infected tissues (Figure 4G–H).
Little GFP staining was found in the ∆US18-infected tis-
sues (Figure 4H) while substantial levels of GFP staining
were detected in tissues infected with ∆RL9 and TowneBAC
(Figure 4E–F, data not shown). These observations sup-
port the growth analysis results (Figure 5) and show that
∆US18 is deficient in infection and replication in gingival
tissues. Second, Western analyses were used to examine
the expression of viral proteins. As shown in Figure 6, at
72 hours post infection, the expression levels of IE1,
UL44, and UL99 in ∆US18-infected tissues were minimal
and significantly lower than those in TowneBAC-infected
tissues. Thus, the infection of ∆US18 appeared to be
blocked prior to or at viral immediate-early gene expres-
sion, probably during viral entry, decoating, or transport-
ing the capsid to the nuclei. Because similar levels of these
proteins were found in tissues that were infected with
∆RL9 and TowneBAC (Figure 6), the presence of the KAN
cassette in the viral genome (e.g. ∆RL9) per se does not
significantly affect viral protein expression in the tissues.
These observations suggest that the defect in protein
expression of ∆US18 may be due to the deletion of the
US18 ORF.
Inhibition of HCMV growth in human oral tissues after 
ganciclovir treatment
One of our objectives is to establish an in vitro cultured
tissue model to screen antiviral compounds and deter-
mine their potency in inhibiting HCMV growth and repli-
cation in human oral tissue. To determine the feasibility
of using the gingival tissue for antiviral compound screen-
ing and testing, two sets of experiments were carried out
using ganciclovir, which functions as a nucleoside analog
and is effective in treating HCMV infection in vivo by
blocking viral DNA replication [31,32]. In the first set of
experiment, oral tissues were treated with different con-
centrations of ganciclovir for 4 hours prior to viral infec-
tion. In the second set of experiments, tissues were
infected with TowneBAC for 24 hours and then treated with
different concentrations of ganciclovir. The tissues were
harvested at different time points post infection and the
growth of HCMV was assayed by determining the viral tit-
ers. Treatment of ganciclovir reduced the growth of HCMV
in HFFs (Figure 7A) [31,32]. Significant inhibition of
HCMV growth was also observed in the gingival tissues
when ganciclovir was added 24 hours after viral infection
(Figure 7B). Similar levels of inhibition of viral growth in
Hematoxylin/eosin (A-B and G) and fluorescent staining (C-F, ) of EpiGi gival tissuesFigure 4
Hematoxylin/eosin (A-B and G) and fluorescent staining (C-F, 
H) of EpiGingival tissues. The tissues were either mock 
infected (A, C) or infected with 2 × 104 PFU of HCMV 
mutant ∆US18 (G and H) and the parental TowneBAC (B, D, 
E, and F), harvested at 7 days post infection, fixed with Streck 
Tissue Fixative, frozen in 2-methylbutane submerged in liquid 
nitrogen, and cross-sectioned at 9 µm using a LEICA cryostat 
LC1900 sectioner, stained with either hematoxylin/eosin or 
DAPI, and visualized (magnification, ×400). The cells that 
were infected with TowneBAC and ∆US18, which carried a 
GFP expression cassette, were visualized by detecting the 
expression of GFP (C, E, F, and H). The images of the DAPI-
staining tissues (DAPI) (D) and the infected cells that 
expressed the GFP (GFP) (E) were used to generate the 
composite image (GFP+DAPI) (F). Similar composite images 
(GFP+DAPI) are shown in (C) and (H).Page 6 of 13
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with the drug before viral infection (data not shown). Pre-
vious studies have shown that treatment of ganciclovir
blocks HCMV infection in cultured fibroblasts regardless
whether the drug was added before or 24 hours after viral
infection [31,32]. These results strongly suggest that cul-
tured gingival tissues can be a suitable model for screening
and testing antiviral compounds for inhibiting HCMV
growth and replication.
Discussion
The oral mucosal epithelia represent one of the most com-
mon sites encountered with microbial organisms for
infection and transmission [39-41]. Both commensal
(nonpathogenic) and pathogenic bacteria and yeast have
been found in the epithelia [39,40]. The mucosa surface
also appears to be susceptible to infection by a variety of
viruses including HCMV, herpes simplex virus, HIV, and
human papillomavirus [7,41]. The development of
human reconstructed tissues of the oral cavity that exhibit
the differentiated characteristics found in vivo will pro-
vide excellent research tools to study the biology of infec-
tions by these pathogens, to screen antimicrobial
compounds, and to develop therapies against oral dis-
eases associated with these infections.
HCMV primarily propagates and replicates in human
cells, and there are few animal models available to study
HCMV infection and pathogenesis [1,2]. Little is known
whether cultured human oral tissues can support HCMV
lytic replication in vitro and be used to study HCMV infec-
tion. In this study, we have characterized the infection of
HCMV in a cultured gingival tissue model. Several lines of
evidence presented in this study strongly suggest that the
cultured oral tissues support HCMV replication, and can
be used as a model for studying HCMV pathogenesis,
screening antivirals, and developing therapies for treating
CMV infections in the oral cavity. First, the cultured tissue
morphology and architecture used in our experiments was
histologically similar to that found in vivo (Figure 1). Tis-
sue structure remained intact for up to 10 days in the
uninfected tissues. Hematoxylin and eosin staining
showed no significant changes in tissue structure, except
increased cornification and cell proliferation toward the
apical surface (Figure 4A). These results suggest that our
cultured conditions do not significantly affect the contin-
uous differentiation and growth of the tissues and that the
tissues exhibit similar characteristics found in vivo.
Second, both laboratory-adapted "high passage" Towne
strain and clinical "low passage" Toledo strain were able
Growth of HCMV mutants ∆US18, ∆RL9, and the parental TowneBAC in cultured cells (A) and gingival tissues (B)Figure 5
Growth of HCMV mutants ∆US18, ∆RL9, and the parental TowneBAC in cultured cells (A) and gingival tissues (B). In (A), 
human foreskin fibroblasts (HFFs) (1 × 106 cells) were infected with each virus at a MOI of 0.05. At 0, 2, 4, 7, 10, and 14 days 
post infection, cells and culture media were harvested and sonicated. In (B), the tissues were infected with 2 × 104 PFU of each 
virus at the apical surface of the tissue. At 0, 3, 6, and 10 days post infection, the tissues were harvested, suspended in 10% 
milk, and sonicated. The viral titers were determined by plaque assays on HFFs. The limit of detection was 10 PFU/ml of the 
tissue homogenate. The values of the viral titer represent the average obtained from triplicate experiments. The standard devi-
ation is indicated by the error bars.Page 7 of 13
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tion (Figure 2). An increase of at least 300-fold in viral tit-
ers was found in the infected tissues after a 10-day
infection period. Thus, HCMV can replicate in the cul-
tured tissue as it does in vivo in oral tissues.
Third, viral lytic proteins, IE1, UL44, and UL99, were
detected in cultured tissues (Figure 3). These proteins are
commonly found in infected tissues in vivo, with IE1,
UL44, and UL99 expressed at the immediate-early, early,
and late stage of the HCMV lytic replication cycle, respec-
tively [2]. These results suggest that HCMV infection in the
cultured tissues exhibits similar gene and protein expres-
sion profiles as found in vivo.
Fourth, fluorescence microscopy experiments indicated
that HCMV can spread within the cultured tissue as
observed in vivo (Figure 4). TowneBAC, which carries a
GFP expression cassette and a BAC sequence [36], was
used in our experiments. Viral infection and spread can be
monitored by detecting the GFP expression. HCMV
spread started from the apical surface, the inoculation site,
to the suprabasal regions in the tissues. Initial viral infec-
tion at the apical surface and subsequent spread to the
suprabasal region have been observed in oral mucosa in
vivo and are believed to represent a common route for
viral transmission among casual contacts [1]. Active
HCMV replication led to lysis of infected cells, damage of
tissues, and reduced thickness of the cornified cell layers
in the cultured oral tissues (Figure 4). Similar observa-
tions are found in vivo, as uncontrolled replication of
HCMV leads to lesions and ulcers in the oral epithelia
[1,9,11]. Thus, HCMV infection in cultured oral tissues
appears to cause similar cytopathic effects and pathologi-
cal changes as found in vivo.
Fifth, treatment with ganciclovir, which is effective in
treating HCMV infection in vivo [31,32], abolished the
growth of HCMV in cultured tissues (Figure 7). These
results indicate that the cultured tissue model can be used
for screening antiviral compounds for blocking HCMV
infection and replication in the oral cavity.
The availability of a cultured oral mucosa model will pro-
vide a unique opportunity to study HCMV pathogenesis
in oral tissues and to identify viral determinants responsi-
ble for HCMV infection in oral cavity. We have initiated a
series of experiments to use the cultured tissues to screen
a pool of viral mutants with deletions in different HCMV
ORFs (Table 1). ∆US18 was found to be defective in
growth in the cultured tissues (Figure 5). These observa-
tions suggest that HCMV encodes specific determinants
for its infection and replication in the oral mucosa. More-
over, these results validate the use of the cultured tissue as
a model for identifying viral genes important for oral
Expression of HCMV lytic proteins as determined by West-ern blot a alysisFigure 6
Expression of HCMV lytic proteins as determined by West-
ern blot analysis. Protein samples were isolated from the cul-
tured EpiGingival tissues that were either mock-infected 
(lanes 1, 5, 9, and 13) or infected with HCMV (2 × 104 PFU) 
(lanes 2–4, 6–8, 10–12, and 14–16) for 72 hours, separated in 
SDS-polyacrylamide gels, and then transferred to mem-
branes. One membrane was allowed to react with a mono-
clonal antibody (Anti-actin) against human actin (D) while the 
others were stained with the antibodies (Anti-IE1, Anti-
UL44, and Anti-UL99) against HCMV IE1, UL44, or UL99, 
respectively (A-C).Page 8 of 13
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replicates and causes viral-associated diseases in oral cav-
ity.
The function of US18 is currently unknown. US18 is only
found in the HCMV genome and no sequence homo-
logues are found in other human herpesviruses or rodent
CMVs (e.g. murine CMV (MCMV)) [14,15,38]. It is
believed that some genes from a particular CMV (e.g.
HCMV) might have co-evolved with its respective host
and interacted with specific components of the host and
therefore, are unique and may not share significant
sequence homologies with CMVs from other species (e.g.
MCMV). For example, US11 and US28, which are dispen-
sable for HCMV replication in vitro, function to down-
regulate the major histocompatibility complex (MHC)
class I molecules and stimulate vascular smooth muscle
cell migration, respectively [42,43]. While little is known
about CMV determinants important for viral infection in
the oral mucosa, previous studies have shown that sali-
vary gland gene 1 (sgg1), a gene that is unique to MCMV
and is dispensable for viral replication in vitro, is impor-
tant for MCMV infection in salivary glands [44]. Likewise,
the function of US18 may be involved in species-specific
interactions between HCMV and humans, such as the
potential interactions in the apical surface of oral epithe-
lia. Like US11 and US28, US18 is dispensable for HCMV
replication in vitro since ∆US18 grows as well as the
parental TowneBAC in human fibroblasts (Figure 5A).
US18 has been predicted to encode a membrane protein
[14,15,38] and is found to be expressed predominantly in
the cytoplasm [45]. Our results of Western analysis and
examination of the ∆US18-infected tissues (Figures 4 and
6) suggest that the infection of ∆US18 is very limited and
may be blocked prior to or at the step of viral immediate-
early gene expression, possibly during viral entry, decoat-
ing, or transporting the capsids to the nuclei.
To confirm the assignment of functionality of a particular
viral gene (e.g. US18), it is probably necessary to restore
the mutation back to the wild type sequence and deter-
mine whether the phenotype of the rescuant viruses is
similar to that of the parental virus. However, the rescue
procedures may potentially introduce adventitious muta-
tions that occur elsewhere in the genome. Meanwhile, it is
possible that the deletion of a target ORF (e.g. US18)
might affect the expression of other viral genes, including
those in nearby regions, as the deleted region may func-
tion as a regulatory element important for the expression
of these genes, in addition to encoding the target ORF.
Extensive studies are needed to demonstrate that the dele-
tion does not affect any other gene expression in the viral
Growth of HCMV in cultured cells (A) and gingival tissues (B) that were treated with different concentrations of ganciclovirFigure 7
Growth of HCMV in cultured cells (A) and gingival tissues (B) that were treated with different concentrations of ganciclovir. In 
(A), human foreskin fibroblasts (HFFs) (1 × 106 cells) were infected with each virus at a MOI of 0.05. At 0, 2, 4, 7, 10, and 14 
days post infection, cells and culture media were harvested and sonicated. In (B), the tissues were infected with 2 × 104 PFU of 
TowneBAC at the apical surface of the tissue. At 0, 3, 6, and 10 days post infection, the tissues were harvested, suspended in 
10% milk, and sonicated. Different concentrations (10 µM or 100 µM) of GCV were added to the cultured media at 24 hours 
post infection. The viral titers were determined by plaque assays on HFFs. The limit of detection was 10 PFU/ml of the tissue 
homogenate. The values of the viral titer represent the average obtained from triplicate experiments. The standard deviation is 
indicated by the error bars.Page 9 of 13
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tle mutation, such as point mutations, to inactivate the
ORF can be generated. Examination of the phenotype of
this second isolate should confirm the results obtained
from the first mutant. Further characterization of these
mutants and the genes mutated will identify the HCMV
determinants important for viral pathogenesis and eluci-
date the functional roles of these ORFs in HCMV infec-
tion.
Our results demonstrate that the cultured tissues provide
a useful system to study HCMV pathogenesis and to iden-
tify viral determinants responsible for HCMV infection in
oral cavity. However, fully differentiated gingival tissues
currently can be maintained in vitro for only a very lim-
ited period of time (~10–14 days). In our experience, after
11 days of culture upon arrival, the tissues began to dete-
riorate and their structures and morphologies changed
(data not shown). Thus, the cultured tissues currently can
only be used to study HCMV lytic but not latent infection.
Further studies, such as tissue engineering and improving
culture conditions and media compositions, will facilitate
the development of this exciting model to study oral biol-
ogy and infections. Investigation of HCMV infection and
characterization of different viral strains and mutants in
these cultured tissues will provide valuable insight into
the mechanism of how HCMV infects oral epithelia,
achieves successful transmission, and causes viral-associ-
ated oral complications. Furthermore, these results will
facilitate the development of new compounds and novel
strategies for treating CMV-associated oral lesions and
preventing viral transmission.
Conclusion
In this report, we investigated the infection of HCMV in a
cultured gingival tissue model and determined whether
the cultured tissue can be used to study HCMV infection
in the oral mucosa. HCMV replicated in the cultured tis-
sues that were infected through the apical surface, spread
from the apical surface to the basal region, and reduced
the thickness of the stratum coreum at the apical region.
Our results that a mutant with a deletion of open reading
frame US18 is deficient in growth in the tissues provided
the first direct evidence to suggest that HCMV encodes
specific determinants for its infection in gingival tissues.
Viral infection in these tissues resembled HCMV lytic rep-
lication observed in vivo and was inhibited by treatment
of ganciclovir. These results suggest that the cultured gin-
gival tissue can be used as a cultured human tissue model
for studying HCMV infection and for screening antivirals
to block viral replication and transmission in the oral cav-
ity.
Methods
Viruses and cells
Primary human foreskin fibroblasts (HFFs) (CC-2509)
from Clonetics (San Diego, CA) were cultured in a humid-
ified incubator at 37°C and in the presence of 5% CO2.
Cells were maintained in Dulbecco's modified Eagle
medium (DMEM) supplemented with 10% (vol/vol) fetal
bovine serum (GIBCO/BRL), 1% (vol/vol) penicillin-
streptomycin (GIBCO/BRL), and 0.2% (vol/vol) fungi-
zone amphotericin B (GIBCO/BRL) [23]. The HCMV
Towne strain was obtained from the American Type Cul-
ture Collection (ATCC, Rockville, MD). The Toledo strain
was a gift from Dr. Edward Mocarski (Stanford University)
[16,35]. TowneBAC and all the mutant viruses used in this
study have been described previously [23,36] and were
propagated in HFFs.
Viral infection of human tissue
Human gingival tissues (EpiGingival), obtained from
MatTek Co (Ashland, MA), are living reconstructed oral
epithelial tissues of 10–20 layers of cells that are derived
from human primary oral keratinocytes and allowed to
differentiate to a structure characteristic to that in vivo
[22]. The tissues arrived in Millipore Millicell CM culture
insert wells and were approximately 0.1 mm thick and 9
mm in diameter. After overnight refrigeration (4°C, man-
ufacturer's recommendations), the tissues were equili-
brated by transferring them to 6 well plates containing 5
ml of assay media (MatTek Co.) per well and incubated at
37°C and 5% CO2 for 1 hour. A small volume of 2 × 104
PFU HCMV (0.1~0.2 ml) was then directly added to the
apical surface of the tissues. After incubation with the viral
inoculum at 37°C and 5% CO2 for 4 hours, the tissues
were washed to remove the inoculum. The tissues were
replenished with fresh serum-free media containing
growth factors every 48 hours. At different time points
post infection, the tissues were collected and processed for
determination of viral titers and for histochemical and
fluorescent microscopy analysis.
Analysis of the growth of viruses in human oral tissues
The tissues were suspended in a small volume of 10%
skim milk, followed by sonication. The tissue homoge-
nates were titered for viral growth on HFFs in 6-well tissue
culture plates (Corning Inc., Corning, NY) [23]. Cells were
inoculated with 1 ml of the sonicated tissues in 10-fold
serial dilutions. After two hours of incubation at 37°C
and 5% CO2, cells were washed with complete media,
overlaid with fresh complete medium containing 1% aga-
rose, and cultured for 7–10 days. Plaques were counted
under an inverted microscope. Each sample was titered in
triplicate and viral titers were recorded as PFU/ml of tissue
homogenates. The limit of virus detection in the tissue
homogenates was 10 PFU/ml of the sonicated mixture.Page 10 of 13
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Tissue preparation and processing for histological studies
Human oral tissues were fixed in Streck Tissue Fixative
(Streck Laboratories, La Vista, NE) and then placed in
30% sucrose overnight. To prepare for cryostat sectioning,
tissues were embedded in Histo Prep (Fisher Scientific,
Fair Lawn, NJ) and frozen in 2-methylbutane submerged
in liquid nitrogen. Tissues were cross-sectioned at 9 µm
using a LEICA cryostat LC1900 sectioner, placed on Super-
frost Plus microscopic slides (Fisher Scientific, Pittsburgh,
PA), air-dried at room temperature, and frozen at -80°C
until further use.
In the experiments using hematoxylin and eosin staining,
the tissue slides were rehydrated in ethanol baths,
immersed in Gill's Hematoxylin 3 and 1% eosin Y (Fisher
Scientific, Fair Lawn, NJ), and then dehydrated in ethanol.
Slides were mounted in permanent media and examined
using a Nikon TE300 microscope with a SPOT camera
attached (Diagnostic Instruments, Inc., Detroit, MI). For
experiments using fluorescence staining, the tissue slides
were permeabilized with 1:1 acetone:methanol and
blocked with 0.1% BSA. For direct visualization of GFP
staining, the slides were counterstained with DAPI
(Molecular Probes, Portland, OR) and mounted with
Vectashield (Vector Laboratories, Inc., Burlingame, CA).
For staining with anti-HCMV antibody, the permeabilized
slides were stained with anti-IE1 monoclonal antibody
(Goodwin Institute of Cancer Research, Plantation, FL),
and then with secondary anti-mouse IgG conjugated to
FITC and/or Texas-Red (Vector Laboratories, Inc., Burlin-
game, CA), prior to counterstain with DAPI. Images were
visualized on a Nikon PCM2000 confocal microscope sys-
tem [46]. The monoclonal antibodies against cytokeratins
K13 and K14 were purchased from United States Biologi-
cal (Swampscott, MA).
Western analysis
The tissues were either mock-infected or infected with 2 ×
104 PFU of different HCMV strains and mutants, then
incubated for 0–10 days. Viral proteins were isolated as
described previously [47]. The polypeptides from cell
lysates were separated on either SDS/7.5% polyacryla-
mide gels or SDS/9% polyacrylamide gels cross-linked
with N,N"methylenebisacylamide, and transferred electri-
cally to nitrocellulose membranes. We stained the mem-
branes using the antibodies against HCMV proteins and
human actin in the presence of a chemiluminescent sub-
strate (Amersham Inc, Arlington Heights, IL), and ana-
lyzed the stained membranes with a STORM840
phosphorimager. Quantitation was performed in the lin-
ear range of protein detection [47]. The monoclonal anti-
bodies c1202, c1203s, and c1207, which react with
HCMV proteins UL44, IE1, and UL99; were purchased
from Goodwin Institute for Cancer Research (Plantation,
FL). The monoclonal antibody against human actin was
purchased from Sigma Inc (St Louis, MO).
Treatment of ganciclovir
Two different sets of experiments were carried out to study
the effect of ganciclovir (GCV) [31,32] on HCMV replica-
tion in the oral tissues. First, the tissues were first pre-incu-
bated with different concentrations (i.e. 10 µM and 100
µM) of GCV for 2 hours, and then incubated with the viral
inoculum in the presence of GCV for 4 hours to initiate
HCMV infection. In the second set of experiments, the tis-
sues were incubated with viral inoculum for 4 hours in the
absence of GCV, and then incubated in fresh media in the
absence of GCV for additional 24 hours before adding dif-
ferent concentrations of GCV to the culture. The infected
tissues were incubated in the GCV-containing media for
different periods of time and harvested, and viral titers in
these tissues were determined by plaque assays on HFFs.
Growth kinetics of HCMV in cultured fibroblasts
Growth analyses of different HCMV strains and mutants
in vitro in primary human foreskin fibroblasts (HFFs)
were carried out as described previously [23]. Briefly, 1 ×
106 human foreskin fibroblasts were infected at an MOI of
0.05 PFU per cell. The cells and media were harvested at
0, 2, 4, 7, 10 and 14 days post infection, and viral stocks
were prepared by adding an equal volume of 10% skim
milk, followed by sonication. The titers of the viral stocks
were determined by plaque assays on HFFs in triplicates.
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